143 related articles for article (PubMed ID: 12120913)
1. Hemostatic parameters in Behçet's disease: a reappraisal.
Koşar A; Oztürk M; Haznedaroğlu IC; Karaaslan Y
Rheumatol Int; 2002 May; 22(1):9-15. PubMed ID: 12120913
[TBL] [Abstract][Full Text] [Related]
2. Pathological haemostasis and "prothrombotic state" in Behçet's disease.
Kiraz S; Ertenli I; Oztürk MA; Haznedaroğlu IC; Celik I; Calgüneri M
Thromb Res; 2002 Jan; 105(2):125-33. PubMed ID: 11958802
[TBL] [Abstract][Full Text] [Related]
3. Behçet's disease: new insight into the relationship between procoagulant state, endothelial activation/damage and disease activity.
Fernández-Bello I; López-Longo FJ; Arias-Salgado EG; Jiménez-Yuste V; Butta NV
Orphanet J Rare Dis; 2013 May; 8():81. PubMed ID: 23711081
[TBL] [Abstract][Full Text] [Related]
4. Vascular involvement in Behçet's disease: relation with thrombophilic factors, coagulation activation, and thrombomodulin.
Espinosa G; Font J; Tàssies D; Vidaller A; Deulofeu R; López-Soto A; Cervera R; Ordinas A; Ingelmo M; Reverter JC
Am J Med; 2002 Jan; 112(1):37-43. PubMed ID: 11812405
[TBL] [Abstract][Full Text] [Related]
5. Cardiac and great vessel thrombosis in Behçet's disease.
Ozatli D; Kav T; Haznedaroglu IC; Büyükaşik Y; Koşar A; Ozcebe O; Dündar SV
Intern Med; 2001 Jan; 40(1):68-72. PubMed ID: 11201375
[TBL] [Abstract][Full Text] [Related]
6. The association between P selectin glycoprotein ligand 1 gene variable number of tandem repeats polymorphism and risk of thrombosis in Behçet's disease.
Cosan F; Oku B; Gedar Totuk OM; Abaci N; Ustek D; Diz Kucukkaya R; Gul A
Int J Rheum Dis; 2018 Dec; 21(12):2175-2179. PubMed ID: 28809090
[TBL] [Abstract][Full Text] [Related]
7. Do hemorheological alterations play any role in the development of thrombotic events in Behçet's disease?
Vayá A; Ricart J; Todolí J; Micó L; Contreras T; Aznar J
Clin Hemorheol Microcirc; 2004; 30(3-4):411-4. PubMed ID: 15258375
[TBL] [Abstract][Full Text] [Related]
8. Thrombin activatable fibrinolysis inhibitor in Behçet's disease.
Donmez A; Aksu K; Celik HA; Keser G; Cagirgan S; Omay SB; Inal V; Aydin HH; Tombuloglu M; Doganavsargil E
Thromb Res; 2005; 115(4):287-92. PubMed ID: 15668188
[TBL] [Abstract][Full Text] [Related]
9. Why are male patients with Behçet's disease prone to thrombosis? A rotational thromboelastographic analysis.
Kara Kivanc B; Gönüllü E; Akay OM; Ertürk A; Bal C; Cansu DÜ; Korkmaz C
Clin Exp Rheumatol; 2018; 36(6 Suppl 115):63-67. PubMed ID: 29998845
[TBL] [Abstract][Full Text] [Related]
10. The role of hemostatic mechanisms in the development of thrombosis in Behcet's disease: an analysis by modified rotation thromboelastogram (ROTEM).
Yaşar Bilge NŞ; Akay OM; Kaşifoğlu T; Kuş G; Korkmaz C
Clin Rheumatol; 2013 Dec; 32(12):1815-8. PubMed ID: 23975360
[TBL] [Abstract][Full Text] [Related]
11. Increased mean platelet volume in Behçet's disease with thrombotic tendency.
Acikgoz N; Karincaoglu Y; Ermis N; Yagmur J; Atas H; Kurtoglu E; Cansel M; Barutcu I; Pekdemir H; Ozdemir R
Tohoku J Exp Med; 2010 Jun; 221(2):119-23. PubMed ID: 20484842
[TBL] [Abstract][Full Text] [Related]
12. The relationship of serum VEGF and sVEGFR-1 levels with vascular involvement in patients with Behçet's disease.
Sertoglu E; Omma A; Yucel C; Colak S; Sandıkcı SC; Ozgurtas T
Scand J Clin Lab Invest; 2018 Oct; 78(6):443-449. PubMed ID: 30015524
[TBL] [Abstract][Full Text] [Related]
13. Coagulation parameters and plasma total homocysteine levels in Behcet's disease.
Lee YJ; Kang SW; Yang JI; Choi YM; Sheen D; Lee EB; Choi SW; Song YW
Thromb Res; 2002 Apr; 106(1):19-24. PubMed ID: 12165284
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of Mean Platelet Volume in Patients With Behcet's Disease as an Indicator of Vascular Thrombosis.
Ataş H; Canpolat F; Eskioglu F
Arch Iran Med; 2018 Jun; 21(6):234-239. PubMed ID: 29940741
[TBL] [Abstract][Full Text] [Related]
15. Reduced erythrocyte deformability in active and untreated Behçet's disease patients.
Tatlican S; Duran FS; Eren C; Eskioglu F; Dikmenoglu N; Oktay B; Durmazlar SP; Canpolat F
Int J Dermatol; 2010 Feb; 49(2):167-71. PubMed ID: 20465640
[TBL] [Abstract][Full Text] [Related]
16. Factor V gene (1691A and 4070G) and prothrombin gene 20210A mutations in patients with Behçet's disease.
Ateş A; Düzgün N; Ulu A; Tiryaki AO; Akar N
Pathophysiol Haemost Thromb; 2003; 33(3):157-63. PubMed ID: 15170396
[TBL] [Abstract][Full Text] [Related]
17. Circulated activated platelets and increased platelet reactivity in patients with Behçet's disease.
Akar S; Ozcan MA; Ateş H; Gürler O; Alacacioglu I; Ozsan GH; Akkoç N; Ozkan S; Demirkan F; Onen F
Clin Appl Thromb Hemost; 2006 Oct; 12(4):451-7. PubMed ID: 17000890
[TBL] [Abstract][Full Text] [Related]
18. Could be serum uric acid a risk factor for thrombosis and/or uveitis in Behcet's disease?
Atıl A; Deniz A
Vascular; 2018 Aug; 26(4):378-386. PubMed ID: 29360007
[TBL] [Abstract][Full Text] [Related]
19. Decreased erythrocyte deformability in Behçet's disease.
Usküdar O; Erdem A; Demiroğlu H; Dikmenoğlu N
Clin Hemorheol Microcirc; 2005; 33(2):89-94. PubMed ID: 16151256
[TBL] [Abstract][Full Text] [Related]
20. Frosted branch angiitis and cerebral venous sinus thrombosis as an initial onset of neuro-Behçet's disease: a case report and review of the literature.
Ferreira BFA; Rodriguez EEC; Prado LLD; Gonçalves CR; Hirata CE; Yamamoto JH
J Med Case Rep; 2017 Apr; 11(1):104. PubMed ID: 28410605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
